Biopharmaceutical

Acorda Therapeutics Inc (NASDAQ: ACOR), a biopharmaceutical company that develops therapies for neurological disorders, on Tuesday announced that it has acquired Biotie Therapies Oyj (ADR) (NASDAQ: BITI) for $25.60 per ADS. Biotie Therapies is a Finland-based drug development company...

Shares of Auris Medical Holding Ag (NASDAQ: EARS), a development-stage biopharmaceutical company, were trading higher by more than 20 percent at $7.17 late Wednesday morning. Auris Medical's stock is now trading higher by over 40 percent over the past five trading days and are higher by...

Shares of Conatus Pharmaceuticals Inc (NASDAQ: CNAT), a small-cap biopharmaceutical company focused on developing medicines to treat liver diseases, were trading higher by 25 percent at $3.61 early Wednesday morning. Conatus Pharmaceuticals announced after Tuesday's market close that a three-month...

Shares of Otonomy Inc (NASDAQ: OTIC), a clinical-stage bio-pharmaceutical company, plunged more than 5 percent in Tuesday's after-hours session after the company announced a public offering of approximately $100 million of its common stock. Otonomy stated that all shares of the common stock...

Shares of Chimerix Inc (NASDAQ: CMRX) were halted at around 7:25 a.m. ET on Monday. Chimerix, a biopharmaceutical company that develops antivirals in areas of high unmet medical need, announced in a press release that a Phase 3 study for its SUPPRESS of brincidofovir in patients undergoing...